Dr. Andreana Hodgini, DO

NPI: 1821033317
Total Payments
$11,622
2024 Payments
$679.84
Companies
56
Transactions
865
Medicare Patients
1,338
Medicare Billing
$132,983

Payment Breakdown by Category

Food & Beverage$11,581 (99.6%)
Education$41.10 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,581 860 99.6%
Education $41.10 5 0.4%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,424 108 $0 (2024)
Novo Nordisk Inc $1,376 152 $0 (2024)
AstraZeneca Pharmaceuticals LP $854.67 48 $0 (2024)
Supernus Pharmaceuticals, Inc. $847.13 66 $0 (2024)
Lilly USA, LLC $769.28 50 $0 (2024)
GlaxoSmithKline, LLC. $547.47 47 $0 (2023)
Janssen Pharmaceuticals, Inc $542.63 36 $0 (2023)
PFIZER INC. $469.83 42 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $469.60 37 $0 (2023)
Amgen Inc. $394.55 26 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $679.84 43 ABBVIE INC. ($204.41)
2023 $1,771 123 ABBVIE INC. ($329.98)
2022 $1,969 128 ABBVIE INC. ($320.37)
2021 $2,142 146 AbbVie Inc. ($426.93)
2020 $1,170 105 Novo Nordisk Inc ($259.44)
2019 $1,057 93 Novo Nordisk Inc ($288.45)
2018 $1,271 104 Novo Nordisk Inc ($244.83)
2017 $1,563 123 AstraZeneca Pharmaceuticals LP ($233.18)

All Payment Transactions

865 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
09/11/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $4.65 General
Category: NEUROSCIENCE
09/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.94 General
Category: Gastroenterology
08/27/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $12.51 General
Category: NEUROSCIENCE
08/26/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $13.22 General
Category: PAIN
08/21/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $17.37 General
Category: Diabetes
08/16/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $13.84 General
Category: NEUROSCIENCE
08/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $8.16 General
Category: NEUROSCIENCE
08/05/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $17.23 General
Category: Oncology
07/30/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $19.31 General
Category: PAIN
07/29/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.06 General
Category: NEUROSCIENCE
07/22/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $17.77 General
Category: Endocrinology
07/18/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $16.42 General
Category: NEUROSCIENCE
07/15/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $18.43 General
Category: Diabetes
07/15/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $11.53 General
Category: CNS Stimulant for ADHD
07/09/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $14.23 General
Category: NEUROSCIENCE
07/04/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $21.57 General
Category: VILOXAZINE HYDROCHLORIDE
06/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.97 General
Category: Gastroenterology
06/25/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.80 General
Category: NEUROSCIENCE
06/24/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $24.03 General
06/18/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $10.82 General
Category: CNS Stimulant for ADHD
06/13/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.28 General
Category: Cardiovascular and Metabolism
05/13/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.45 General
Category: Gastroenterology
03/21/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $12.61 General
Category: NEUROSCIENCE
03/19/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $19.80 General
Category: Oncology
03/18/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $17.96 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 253 338 $69,918 $24,843
2022 7 279 369 $72,511 $27,125
2021 6 306 443 $88,470 $34,743
2020 10 500 612 $135,436 $46,273
Total Patients
1,338
Total Services
1,762
Medicare Billing
$132,983
Procedure Codes
27

All Medicare Procedures & Services

27 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 82 82 $28,044 $10,059 35.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 84 129 $26,507 $9,267 35.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 74 109 $15,151 $5,477 36.1%
81003 Automated urinalysis test Office 2023 13 18 $216.00 $39.60 18.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 99 99 $31,132 $11,904 38.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 73 125 $25,750 $8,662 33.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 57 88 $12,232 $4,633 37.9%
90732 Pneumococcal vaccine, 23-valent Office 2022 11 11 $2,277 $1,451 63.7%
G0009 Administration of pneumococcal vaccine Office 2022 11 11 $433.00 $302.49 69.9%
83036 Hemoglobin a1c level Office 2022 11 13 $468.00 $124.60 26.6%
81003 Automated urinalysis test Office 2022 17 22 $219.00 $48.77 22.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 108 219 $45,114 $16,655 36.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 109 109 $32,155 $13,742 42.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 50 73 $10,147 $3,904 38.5%
G0009 Administration of pneumococcal vaccine Office 2021 15 15 $525.00 $237.49 45.2%
G0008 Administration of influenza virus vaccine Office 2021 11 11 $385.00 $167.92 43.6%
81003 Automated urinalysis test Office 2021 13 16 $144.00 $36.00 25.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 134 134 $39,530 $14,908 37.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 99 179 $25,061 $7,669 30.6%
90670 Pneumococcal vaccine for injection into muscle Office 2020 28 28 $18,665 $6,424 34.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 76 108 $22,736 $5,868 25.8%
90732 Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older Office 2020 30 30 $8,930 $3,574 40.0%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2020 20 20 $8,740 $3,299 37.7%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2020 13 13 $5,512 $2,088 37.9%
90662 Vaccine for influenza for injection into muscle Office 2020 19 19 $2,299 $1,159 50.4%

About Dr. Andreana Hodgini, DO

Dr. Andreana Hodgini, DO is a Family Medicine healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821033317.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andreana Hodgini, DO has received a total of $11,622 in payments from pharmaceutical and medical device companies, with $679.84 received in 2024. These payments were reported across 865 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,581).

As a Medicare-enrolled provider, Hodgini has provided services to 1,338 Medicare beneficiaries, totaling 1,762 services with total Medicare billing of $132,983. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Fort Wayne, IN
  • Active Since 06/18/2006
  • Last Updated 03/02/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1821033317

Products in Payments

  • Ozempic (Drug) $660.43
  • QELBREE (Drug) $646.10
  • VRAYLAR (Drug) $515.80
  • UBRELVY (Drug) $483.77
  • FARXIGA (Drug) $433.28
  • Kerendia (Drug) $432.71
  • XIFAXAN (Drug) $392.17
  • XARELTO (Drug) $348.47
  • TRELEGY ELLIPTA (Drug) $328.74
  • EMGALITY (Drug) $283.66
  • QULIPTA (Drug) $212.73
  • VYVANSE (Drug) $212.30
  • NURTEC ODT (Drug) $210.01
  • Victoza (Drug) $207.46
  • Aimovig (Biological) $191.67
  • Vascepa (Drug) $179.39
  • BEVESPI AEROSPHERE (Drug) $178.16
  • MOUNJARO (Drug) $173.56
  • SYMBICORT (Drug) $169.32
  • TROKENDI XR (Drug) $166.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Fort Wayne